BioMarin Pharmaceutical Inc. (BMRN) Financials Nov 20,
BioMarin Pharmaceutical Inc. (BMRN) Financials Nov 20, 2014, 5:32 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for BioMarin Pharmaceutical Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 324.66M 376.27M 446M 494.89M 548.45M
Cost of Goods Sold (COGS) incl. D&A 68.82M 76.69M 119.15M 129.95M 136.21M
COGS excluding D&A 47.85M 46.99M 83.06M 84.65M 88.94M
Depreciation & Amortization Expense 20.98M 29.71M 36.09M 45.3M 47.26M
Depreciation 18.06M 23.3M 31.9M 34.9M 36.5M
Amortization of Intangibles 2.91M 6.41M 4.19M 10.4M 10.76M
Gross Income 255.83M 299.58M 326.84M 364.94M 412.24M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 239.41M 299.03M 358.57M 464.82M 550.83M
Research & Development 115.12M 147.31M 214.37M 302.22M 354.78M
Other SG&A 124.29M 151.72M 144.2M 162.6M 196.05M
Other Operating Expense 0 0 0 0 0
Unusual Expense 5.85M 13.73M 4.06M 10.34M 30.42M
EBIT after Unusual Expense (5.85M) (13.73M) (4.06M) (10.34M) (30.42M)
Non Operating Income/Expense 1.59M 902,000 0 (1.79M) 1.02M
Non-Operating Interest Income 5.09M 4.11M 2.93M 2.58M 3.08M
Equity in Affiliates (Pretax) (2.59M) (2.99M) (2.43M) (1.22M) (1.15M)
Interest Expense 14.09M 10.33M 8.35M 7.64M 10.45M
Gross Interest Expense 14.09M 10.33M 8.35M 14.94M 10.45M
Interest Capitalized 0 0 0 7.3M 0
Pretax Income 566,000 (21.49M) (43.63M) (118.28M) (176.5M)
Income Tax 1.05M (227.31M) 10.21M (3.93M) (150,000)
Income Tax - Current Domestic (379,000) 1.64M 4.21M 4.13M 6.56M
Income Tax - Current Foreign 1.43M 1.62M 1.64M 1.86M 2.2M
Income Tax - Deferred Domestic 0 (230.17M) 4.44M (9.95M) (8.74M)
Income Tax - Deferred Foreign 0 (404,000) (78,000) 25,000 (163,000)
Income Tax Credits 0 0 0 0 -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 - - 0 0
Consolidated Net Income (488,000) 205.82M (53.84M) (114.35M) (176.35M)
Minority Interest Expense 0 0 0 0 0
Net Income (488,000) 205.82M (53.84M) (114.35M) (176.35M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - - - 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (488,000) 205.82M (53.84M) (114.35M) (176.35M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (488,000) 205.82M (53.84M) (114.35M) (176.35M)
EPS (Basic) 0.00 2.00 (0.48) (0.95) (1.28)
Basic Shares Outstanding 100.27M 103.09M 112.12M 120.27M 137.76M
EPS (Diluted) 0.00 1.64 (0.48) (0.95) (1.28)
Diluted Shares Outstanding 100.27M 125.67M 112.12M 120.27M 137.76M
EBITDA 37.4M 30.25M 4.37M (54.58M) (91.33M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...
Continue Reading
Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...
Continue Reading
Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...
Continue Reading
Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...
Continue Reading
Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...
Continue Reading
Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...
Continue Reading
Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....
Continue Reading
Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....
Continue Reading
The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...
Continue Reading
When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...
Continue Reading
Top 5 Most Recently Viewed Articles
States Vulnerable to Economic Downturns The landscape of economic stability is shifting, and many residents might be unaware of how their home states rank in terms of recession preparedness. Recent analyses reveal striking differences in resilience that could significantly impact everyday Americans. With numerous warnings about incoming economic turbulence, it’s crucial...
Continue Reading
Liquidia Corporation Announces Significant Funding Boost Liquidia Corporation (NASDAQ: LQDA), a prominent biopharmaceutical company, is thrilled to announce that it has secured an additional $50 million to support the launch of its innovative treatment, YUTREPIA™. This exciting development follows a pivotal legal victory where a U.S. District Court ruled against a...
Continue Reading
Paratus Energy Services Ltd. Reports Mandatory Trade Notification Paratus Energy Services Ltd. has recently announced a significant trade notification involving a close associate of one of its board members. The company, which operates in the energy sector, has revealed that a fund managed by Lodbrok Capital LLP has completed a trade involving its shares. This information...
Continue Reading
Angel's Global Release of David Musical Animated musical builds powerful momentum as early domestic pre-sales surge close to $6 million Angel (NYSE: ANGX), a leading media and technology company championing values-driven stories, is setting the stage for the theatrical release of the eagerly awaited animated musical David across 43 international markets. This significant...
Continue Reading
LifeMD, Inc. Announces Quarterly Dividend LifeMD, Inc. (NASDAQ: LFMD), recognized for its pioneering virtual primary care offerings, has announced an important cash dividend for its shareholders. The Company's Board of Directors has declared a cash dividend of $0.5546875 per share on the 8.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ: LFMDP). This...
Continue Reading